| P50 | author | Michael Jacob Adams | Q73767302 |
| | Stuart R Lipsitz | Q89300629 |
| P2093 | author name string | Gabriela Lopez-Mitnik | |
| | Steven E Lipshultz | |
| | Louis S Constine | |
| | Tracie L Miller | |
| | Andrea S Hinkle | |
| | David C Landy | |
| | Carol A French | |
| | Cindy Proukou | |
| | Amy M Rovitelli | |
| P2860 | cites work | Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood | Q28334880 |
| | Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55,000 vascular deaths | Q31139036 |
| | Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility | Q52232460 |
| | Theoretical and empirical derivation of cardiovascular allometric relationships in children. | Q53840332 |
| | The Relative Ability of Different Propensity Score Methods to Balance Measured Covariates Between Treated and Untreated Subjects in Observational Studies | Q57266791 |
| | Decreasing late mortality among five-year survivors of cancer in childhood and adolescence: a population-based study in the Nordic countries | Q58006773 |
| | Corrected QT interval prolongation in anthracycline-treated survivors of childhood cancer | Q70505768 |
| | Cardiovascular trials in long-term survivors of childhood cancer | Q76389101 |
| | Presence of prolonged dispersion of qt intervals in late survivors of childhood anthracycline therapy | Q78678682 |
| | A clinic-based, comprehensive care model for studying late effects in long-term survivors of pediatric illnesses | Q79860267 |
| | Associations between neurohormonal and inflammatory activation and heart failure in children | Q80758249 |
| | Risk scores predict atherosclerotic lesions in young people | Q81685268 |
| | Cardiotoxicity after childhood cancer: beginning with the end in mind | Q82833695 |
| | Role of cancer treatment in long-term overall and cardiovascular mortality after childhood cancer | Q82833737 |
| | Long-term cause-specific mortality among survivors of childhood cancer | Q84565844 |
| | ??? | Q28275865 |
| | Long-term results of Dana-Farber Cancer Institute ALL Consortium protocols for children with newly diagnosed acute lymphoblastic leukemia (1985-2000). | Q33645760 |
| | Serial measurements of serum NT-proBNP as markers of left ventricular systolic function and remodeling in children with heart failure | Q34241724 |
| | Chronic health conditions in adult survivors of childhood cancer | Q34573463 |
| | Cause-specific late mortality among 5-year survivors of childhood cancer: the Childhood Cancer Survivor Study | Q34835391 |
| | Reliability of multicenter pediatric echocardiographic measurements of left ventricular structure and function: the prospective P(2)C(2) HIV study | Q35016859 |
| | Cardiac dysfunction and mortality in HIV-infected children: The Prospective P2C2 HIV Multicenter Study. Pediatric Pulmonary and Cardiac Complications of Vertically Transmitted HIV Infection (P2C2 HIV) Study Group. | Q35016887 |
| | Mild dilated cardiomyopathy and increased left ventricular mass predict mortality: the prospective P2C2 HIV Multicenter Study. | Q35551783 |
| | Cardiac effects of antiretroviral therapy in HIV-negative infants born to HIV-positive mothers: NHLBI CHAART-1 (National Heart, Lung, and Blood Institute Cardiovascular Status of HAART Therapy in HIV-Exposed Infants and Children cohort study). | Q35626381 |
| | Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the Childhood Cancer Survivor Study cohort | Q35699184 |
| | Stratification and weighting via the propensity score in estimation of causal treatment effects: a comparative study | Q35880034 |
| | Changes in cardiac biomarkers during doxorubicin treatment of pediatric patients with high-risk acute lymphoblastic leukemia: associations with long-term echocardiographic outcomes | Q35925266 |
| | Is physical fitness decreased in survivors of childhood leukemia? A systematic review | Q35938941 |
| | Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study | Q36486430 |
| | Long-term endocrine sequelae of childhood cancer | Q36881328 |
| | Monitoring for cardiovascular disease in survivors of childhood cancer: report from the Cardiovascular Disease Task Force of the Children's Oncology Group. | Q37054768 |
| | Anthracycline associated cardiotoxicity in survivors of childhood cancer | Q37112428 |
| | Assessment of dexrazoxane as a cardioprotectant in doxorubicin-treated children with high-risk acute lymphoblastic leukaemia: long-term follow-up of a prospective, randomised, multicentre trial | Q37129069 |
| | The GH-IGF-I axis and the cardiovascular system: clinical implications | Q37156764 |
| | Predictors of inactive lifestyle among adult survivors of childhood cancer: a report from the Childhood Cancer Survivor Study | Q37215882 |
| | Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia. | Q37287058 |
| | Predicting the 30-year risk of cardiovascular disease: the framingham heart study | Q37356527 |
| | Cardiovascular risk factors in hypopituitary GH-deficient adults | Q37580579 |
| | Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need? | Q39948158 |
| | Characteristics and determinants of adiposity in pediatric cancer survivors. | Q41411183 |
| | Clinical cardiotoxicity following anthracycline treatment for childhood cancer: the Pediatric Oncology Group experience | Q41507395 |
| | Female sex and higher drug dose as risk factors for late cardiotoxic effects of doxorubicin therapy for childhood cancer. | Q42279363 |
| | Early predictors of myocardial disease in children and adolescents with type 1 diabetes mellitus | Q43285668 |
| | Long-term survivors of childhood cancers in the United States | Q43800912 |
| | Body mass index in long-term adult survivors of childhood cancer: a report of the Childhood Cancer Survivor Study | Q45025318 |
| | Growth hormone deficiency predicts cardiovascular risk in young adults treated for acute lymphoblastic leukemia in childhood | Q45096607 |
| | Chronic progressive cardiac dysfunction years after doxorubicin therapy for childhood acute lymphoblastic leukemia | Q46443830 |
| | Cardiac changes associated with growth hormone therapy among children treated with anthracyclines | Q46522560 |
| | Assessment of biventricular functional reserve and NT-proBNP levels in patients with RV volume overload after repair of tetralogy of Fallot at young age. | Q46583020 |
| | Correlation of plasma N-terminal pro-brain natriuretic peptide levels with left ventricle mass in children treated with anthracyclines | Q46806076 |
| | Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy. | Q47949009 |
| | Late anthracycline cardiotoxicity after childhood cancer: a prospective longitudinal study | Q47995881 |
| | Predictive value of B-type natriuretic peptides in detecting latent left ventricular diastolic dysfunction in beta-thalassemia major | Q48332602 |
| | Long-term survivors of childhood cancer have an increased risk of manifesting the metabolic syndrome. | Q51015219 |
| | Early indicators of dysmetabolic syndrome in young survivors of acute lymphoblastic leukemia in childhood as a target for preventing disease. | Q51471888 |
| | Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia. | Q51492907 |
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | childhood cancer | Q5097977 |
| P304 | page(s) | 1050-1057 | |
| P577 | publication date | 2012-03-05 | |
| P1433 | published in | Journal of Clinical Oncology | Q400292 |
| P1476 | title | Cardiovascular status of childhood cancer survivors exposed and unexposed to cardiotoxic therapy | |
| P478 | volume | 30 | |